Pharmaceutical

Pieris Pharma lays off 70% of workforce amid company restructuring

The biotech announced its employee cuts as part of a strategic update partly caused by the termination of its AstraZeneca collaboration.

Jul 19, 2023 - 20:00
Pieris Pharma lays off 70% of workforce amid company restructuring
The biotech announced its employee cuts as part of a strategic update partly caused by the termination of its AstraZeneca collaboration.
Read the original article

Tags:

Previous Article

STAT+: Key House panel plots a new health care package — complicating the chambe...

Next Article

Amarin restructures to counter downturn following Vascepa generics

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: FDA approves Medtronic high blood pressure device despite a negative advisory panel vote

STAT+: FDA approves Medtronic high blood pressure devic...

Nov 17, 2023

STAT+: ‘A tug of war’: Europe braces for new legislation with far-reaching impacts on pharma and patients

STAT+: ‘A tug of war’: Europe braces for new legislatio...

Apr 25, 2023

STAT+: UnitedHealth’s profit jumps as medical costs come in lower than expected

STAT+: UnitedHealth’s profit jumps as medical costs com...

Oct 14, 2023